CAS
IART icon

Coppell Advisory Solutions’s Integra LifeSciences IART Stock Holding History

Coppell Advisory Solutions’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-70
Closed -$1.57K – 1025
2024
Q4 		$1.57K Sell
70
-2,068
-97% -$45.1K ﹤0.01% 1579
2024
Q3 		$38.2K Hold
2,138
– – 0.01% 638
2024
Q2 		$62.3K Buy
+2,138
New +$63.4K 0.01% 445
2023
Q4 		$90.1K Buy
+2,068
New +$81.4K 0.02% 381
2023
Q3 		– Sell
-2,068
Closed -$84.3K – 1347
2023
Q2 		$84.3K Buy
+2,068
New +$99.5K 0.02% 287

Other funds holding IART

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Coppell Advisory Solutions's IART Position: Q1 2025 in Review

Coppell Advisory Solutions sold out of Integra LifeSciences (IART) in Q1 2025, closing a stake of 70 shares — an estimated $1.57K sold.

Coppell Advisory Solutions first reported a position in IART in Q2 2023 and held it in 5 quarters. The position peaked at $90.1K in Q4 2023. 219 funds tracked by Wall St. Rank hold IART as of Q1 2025.

  • Coppell Advisory Solutions reported no remaining Integra LifeSciences position as of Q1 2025 after selling out during the quarter.
  • Coppell Advisory Solutions sold 70 Integra LifeSciences shares in Q1 2025, an estimated $1.57K.
  • Coppell Advisory Solutions first reported a position in Integra LifeSciences in Q2 2023 and held it in 5 quarters.
  • Coppell Advisory Solutions's Integra LifeSciences position peaked at $90.1K in Q4 2023.
  • 219 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2025.

Based on Coppell Advisory Solutions's 13F filing for Q1 2025, filed 16 May 2025.